{"title":"A rational approach for predicting the minimum composition of anti-parasite sub-unit vaccines: a multiple target vaccine hypothesis","authors":"V. Titanji, Jerome Nyhalah Dinga, R. Nyasa","doi":"10.4314/JCAS.V14I1.1","DOIUrl":null,"url":null,"abstract":"The present article introduces a new concept, termed a multiple vaccine target hypothesis (MVTH) for determining the minimum number of vaccine targets (epitopes/antigens) necessary to construct a highly efficacious (greater than 90%) anti-parasite vaccine. Drawing inspiration from the Metabolic Control Analysis (MCA) and immunological reasoning it is proposed that for a multi-stage parasite an effective anti-parasite vaccine will necessarily act on more than one stage of the parasite in the definitive host. It is argued that the minimum number of sub-unit targets for a highly efficacious anti-parasite vaccine will vary from one parasite to the other and will be equal to twice the number of major parasite stages occurring in the human host. Quantitatively stated, C v =2n where C v the number of required targets is, and n represents the number of major parasite stages in the definitive host. Conditions when the value of C v may deviate from what is predicted by the formula given above are discussed. Extensive literature search on malaria, onchocerciasis and schistosomiasis sub-unit vaccine development suggests that subunit vaccines constructed from single components and directed to just one parasite stage are less efficacious that multivariate sub-unit vaccines, and obviously whole parasite vaccines. MVTH therefore provides a rational framework for constituting a sub-unit anti-parasite vaccine. Keywords: Vaccine, malaria, Onchocerca volvulus , schistosomiasis, parasite, equation","PeriodicalId":383706,"journal":{"name":"Journal of the Cameroon academy of sciences","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Cameroon academy of sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/JCAS.V14I1.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
The present article introduces a new concept, termed a multiple vaccine target hypothesis (MVTH) for determining the minimum number of vaccine targets (epitopes/antigens) necessary to construct a highly efficacious (greater than 90%) anti-parasite vaccine. Drawing inspiration from the Metabolic Control Analysis (MCA) and immunological reasoning it is proposed that for a multi-stage parasite an effective anti-parasite vaccine will necessarily act on more than one stage of the parasite in the definitive host. It is argued that the minimum number of sub-unit targets for a highly efficacious anti-parasite vaccine will vary from one parasite to the other and will be equal to twice the number of major parasite stages occurring in the human host. Quantitatively stated, C v =2n where C v the number of required targets is, and n represents the number of major parasite stages in the definitive host. Conditions when the value of C v may deviate from what is predicted by the formula given above are discussed. Extensive literature search on malaria, onchocerciasis and schistosomiasis sub-unit vaccine development suggests that subunit vaccines constructed from single components and directed to just one parasite stage are less efficacious that multivariate sub-unit vaccines, and obviously whole parasite vaccines. MVTH therefore provides a rational framework for constituting a sub-unit anti-parasite vaccine. Keywords: Vaccine, malaria, Onchocerca volvulus , schistosomiasis, parasite, equation
本文引入了一个新概念,称为多疫苗靶点假说(MVTH),用于确定构建高效(大于90%)抗寄生虫疫苗所需的疫苗靶点(表位/抗原)的最小数量。从代谢控制分析(MCA)和免疫学推理中得到启发,提出对于多阶段寄生虫,有效的抗寄生虫疫苗必须作用于最终宿主中寄生虫的多个阶段。有人认为,一种高效的抗寄生虫疫苗的最小亚单位靶标数量将因寄生虫而异,并且将等于人类宿主中发生的主要寄生虫阶段数量的两倍。定量地说,C v =2n,其中C v为所需靶标的数量,n为最终宿主中主要寄生虫阶段的数量。讨论了cv值可能偏离上述公式所预测值的情况。对疟疾、盘尾丝虫病和血吸虫病亚单位疫苗开发的广泛文献检索表明,由单一组分构建的亚单位疫苗仅针对一个寄生虫阶段,其效果不如多组分亚单位疫苗,明显不如整个寄生虫疫苗。因此,MVTH为构建亚单位抗寄生虫疫苗提供了合理的框架。关键词:疫苗,疟疾,盘尾丝虫病,血吸虫病,寄生虫,方程